|
|
Article: IMITREX(R) TABLETS NOW AVAILABLE FOR PEOPLE WITH MIGRAINE IN THE U.S. FIRST HIGHLY SELECTIVE MIGRAINE THERAPY IN TABLET FORM
- Article from:
- PR Newswire
- Article date:
- September 6, 1995
CopyrightCOPYRIGHT 1995 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
RESEARCH TRIANGLE PARK, N.C., Sept. 6 /PRNewswire/ -- The tablet form of Imitrex(R) (sumatriptan succinate), the breakthrough therapy for the acute treatment of migraine, is now available to consumers in the United States by prescription. Since 1993, Imitrex has been available in the U.S. by subcutaneous (beneath the skin) injection form only. Imitrex was developed and is marketed by Glaxo Wellcome Inc.
The introduction of Imitrex Tablets will mark availability of the first and only highly selective 5-HT1 (see note) receptor-agonist migraine therapy in a tablet form. In worldwide markets, tablets account for more than 80 percent of sumatriptan sales.
...